Cara Therapeutics Earnings Calls

Q4 2024 (Upcoming)
Release date Mar 03, 2025
EPS estimate -
EPS actual -
Revenue estimate -
Revenue actual -
Expected change +/- 7.14%
Q3 2024 Beat
-$1.80 (40.00%)
Release date Nov 14, 2024
EPS estimate -$3.00
EPS actual -$1.80
EPS Surprise 40.00%
Revenue estimate 1.596M
Revenue actual 2.556M
Revenue Surprise 60.15%
Q2 2024 Missed
-$0.370 (-27.59%)
Release date Aug 14, 2024
EPS estimate -$0.290
EPS actual -$0.370
EPS Surprise -27.59%
Revenue estimate 1.17M
Revenue actual 991K
Revenue Surprise -15.30%
Q1 2024 Missed
-$0.560 (-47.37%)
Release date May 13, 2024
EPS estimate -$0.380
EPS actual -$0.560
EPS Surprise -47.37%
Revenue estimate 1.69M
Revenue actual 2.135M
Revenue Surprise 26.33%

Last 4 Quarters for Cara Therapeutics

Below you can see how CARA performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Q1 2024 Missed
Release date May 13, 2024
Fiscal end date Mar 31, 2024
Price on release $0.750
EPS estimate -$0.380
EPS actual -$0.560
EPS surprise -47.37%
Date Price
May 07, 2024 $0.792
May 08, 2024 $0.733
May 09, 2024 $0.760
May 10, 2024 $0.716
May 13, 2024 $0.750
May 14, 2024 $0.724
May 15, 2024 $0.760
May 16, 2024 $0.81
May 17, 2024 $0.750
4 days before -5.29%
4 days after -0.0267%
On release day -3.56%
Change in period -5.31%
Q2 2024 Missed
Release date Aug 14, 2024
Fiscal end date Jun 30, 2024
Price on release $0.329
EPS estimate -$0.290
EPS actual -$0.370
EPS surprise -27.59%
Date Price
Aug 08, 2024 $0.351
Aug 09, 2024 $0.348
Aug 12, 2024 $0.337
Aug 13, 2024 $0.338
Aug 14, 2024 $0.329
Aug 15, 2024 $0.325
Aug 16, 2024 $0.335
Aug 19, 2024 $0.324
Aug 20, 2024 $0.339
4 days before -6.38%
4 days after 3.10%
On release day -1.10%
Change in period -3.48%
Q3 2024 Beat
Release date Nov 14, 2024
Fiscal end date Sep 30, 2024
Price on release $0.328
EPS estimate -$3.00
EPS actual -$1.80
EPS surprise 40.00%
Date Price
Nov 08, 2024 $0.340
Nov 11, 2024 $0.341
Nov 12, 2024 $0.341
Nov 13, 2024 $0.324
Nov 14, 2024 $0.328
Nov 15, 2024 $0.311
Nov 18, 2024 $0.293
Nov 19, 2024 $0.301
Nov 20, 2024 $0.305
4 days before -3.62%
4 days after -6.90%
On release day -5.04%
Change in period -10.27%
Q4 2024 (Upcoming)
Release date Mar 03, 2025
Fiscal end date Dec 30, 2024
Price on release -
EPS estimate -
EPS actual -
Date Price
Feb 06, 2025 $5.12
Feb 07, 2025 $5.06
Feb 10, 2025 $5.04
Feb 11, 2025 $5.15
Feb 12, 2025 $5.25

Cara Therapeutics Earnings History

Earnings Calendar

FAQ

When is the earnings report for CARA?
Cara Therapeutics (CARA) has scheduled its earnings report for Mar 03, 2025 before the markets open.

What is the CARA price-to-earnings (P/E) ratio?
CARA P/E ratio as of Feb 12, 2025 (TTM) is -2.89.

What is the CARA EPS forecast?
The forecasted EPS (Earnings Per Share) for Cara Therapeutics (CARA) for the first fiscal quarter 2024 is $.

What are Cara Therapeutics's retained earnings?
On its balance sheet, Cara Therapeutics reported retained earnings of $2.56 million for the latest quarter ending Sep 30, 2024.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT CARA THERAPEUTICS
Cara Therapeutics
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod...
GOLDEN STAR
Ticker Change Signal Date
LFUS
$234.72
3.32% Feb 10
ITW
$255.56
0.192% Feb 07
O
OBDC
$15.00
2.20% Feb 07
GGB
$2.95
2.37% Feb 06
BUD
$49.11
6.45% Feb 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE